KEGG   DRUG: D02737Help
Entry
D02737                      Drug                                   

Name
Palivizumab (genetical recombination) (JAN);
Palivizumab (INN);
Synagis (TN)
Product
Activity
Monoclonal antibody [DS:H00401]
Remark
Therapeutic category: 
ATC code: 
Target
RSV F protein
Interaction
Drug interaction
Structure map
Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BB Specific immunoglobulins
     J06BB16 Palivizumab
      D02737  Palivizumab (genetical recombination) (JAN); Palivizumab (INN)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D02737  Palivizumab (genetical recombination) (JAN); Palivizumab (INN)
Antiinfectives [BR:br08307]
 Antivirals
  Others
   Anti-RSV agent
    Anti-RSV F protein monoclonal antibody
     Palivizumab
      D02737  Palivizumab (genetical recombination) (JAN); Palivizumab (INN)
BRITE hierarchy
Other DBs
CAS: 
188039-54-5
PubChem: 
DrugBank: 

» Japanese version   » Back

DBGET integrated database retrieval system